
David G. Mitchell, PharmD, MBA, CSP, FCPhA, of UC Davis Health, explains how AI-assisted prior authorizations have reduced denials and staff time without replacing pharmacist judgment.
Dr. Jonathan Meyer describes the unmet needs related to the pharmacologic management of schizophrenia.
Dr. Jonathan Meyer, Associate Clinical Professor of Psychiatry at the University of California at San Diego, talks about unmet needs related to the pharmacologic management of schizophrenia.